HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential induction of premature chromosome condensation by calyculin A in human fibroblast and tumor cell lines.

Abstract
The feasibility of chemically-induced premature chromosome condensation (PCC) was tested in two human fibroblast and two human malignant melanoma cell lines. To induce PCCs, calyculin A, a potent protein phosphatase inhibitor, was used at a final concentration of 80 nM. Attached cells and cells put into suspension by trypsinization were incubated with calyculin A at 37 degrees C for 1 hour. Calyculin A was able to induce PCCs in all the phases of the cell cycle with the tumour cell lines giving the highest PCC frequency. No systematic differences were observed between attached cells and cells put into suspension by trypsinization. However, a cytotoxic effect that led to the loss of 50% to 80% of the treated cells was observed. The cytotoxic effect was more severe in the fibroblast than in the tumour cell lines. The appearance of deformed, fragile and fragmented nuclei with no particular chromatin condensation would explain to some extent this cytotoxic effect. A better understanding of the mechanism of action of calyculin A would help generalizing its use to study interphase chromosome aberrations.
AuthorsG Alsbeih, G P Raaphorst
JournalAnticancer research (Anticancer Res) 1999 Mar-Apr Vol. 19 Issue 2A Pg. 903-8 ISSN: 0250-7005 [Print] Greece
PMID10368632 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Marine Toxins
  • Oxazoles
  • calyculin A
  • Phosphoprotein Phosphatases
Topics
  • Apoptosis (drug effects)
  • Cell Line
  • Chromosomes, Human (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Fibroblasts (drug effects, ultrastructure)
  • Humans
  • Marine Toxins
  • Oxazoles (pharmacology)
  • Phosphoprotein Phosphatases (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: